Lixte Biotechnology Correlations

LIXT Stock

USD 1.22 0.13 9.63%

The current 90-days correlation between Lixte Biotechnology and Allarity Therapeutics is -0.24 (i.e., Very good diversification). The correlation of Lixte Biotechnology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Lixte Biotechnology Correlation With Market

Good diversification

The correlation between Lixte Biotechnology Holdings and DJI is -0.08 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Lixte Biotechnology Holdings and DJI in the same portfolio, assuming nothing else is changed.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lixte Biotechnology Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

Moving together with Lixte Stock

0.69	SCLX	Scilex Holding	Pair Corr
0.67	ASMB	Assembly Biosciences Downward Rally	Pair Corr
0.8	CMND	Clearmind Medicine Common	Pair Corr
0.66	MLSS	Milestone Scientific Earnings Call Today	Pair Corr
0.72	CAT	Caterpillar	Pair Corr
0.67	HD	Home Depot	Pair Corr

Moving against Lixte Stock

0.67	LUCD	Lucid Diagnostics	Pair Corr
0.57	PG	Procter Gamble	Pair Corr
0.49	WM	Waste Management	Pair Corr
0.69	JNJ	Johnson Johnson	Pair Corr
0.69	T	ATT Inc Aggressive Push	Pair Corr
0.59	INTC	Intel	Pair Corr
0.45	DD	Dupont De Nemours	Pair Corr
0.44	IBM	International Business	Pair Corr
0.34	XOM	Exxon Mobil Corp Earnings Call This Week	Pair Corr
0.33	CSCO	Cisco Systems Aggressive Push	Pair Corr

Related Correlations Analysis

	ALLR	NRBO	HILS	VRAX	QNRX	INDP	KTTA	KRBP	BDRX	PMVP
ALLR		0.43	0.0	0.24	0.15	0.38	0.49	0.0	0.28	0.12	ALLR
NRBO	0.43		0.0	0.57	0.7	0.74	0.83	0.0	0.56	0.62	NRBO
HILS	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	HILS
VRAX	0.24	0.57	0.0		0.74	0.68	0.75	0.0	0.71	0.69	VRAX
QNRX	0.15	0.7	0.0	0.74		0.62	0.83	0.0	0.46	0.6	QNRX
INDP	0.38	0.74	0.0	0.68	0.62		0.71	0.0	0.56	0.56	INDP
KTTA	0.49	0.83	0.0	0.75	0.83	0.71		0.0	0.65	0.74	KTTA
KRBP	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	KRBP
BDRX	0.28	0.56	0.0	0.71	0.46	0.56	0.65	0.0		0.77	BDRX
PMVP	0.12	0.62	0.0	0.69	0.6	0.56	0.74	0.0	0.77		PMVP
	ALLR	NRBO	HILS	VRAX	QNRX	INDP	KTTA	KRBP	BDRX	PMVP

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

KTTA	+ 0.83	NRBO
KTTA	+ 0.83	QNRX
PMVP	+ 0.77	BDRX
KTTA	+ 0.75	VRAX
INDP	+ 0.74	NRBO
QNRX	+ 0.74	VRAX

High negative correlations

PMVP	- 0.0	KRBP
BDRX	- 0.0	KRBP
KRBP	- 0.0	KTTA
KRBP	- 0.0	INDP
KRBP	- 0.0	QNRX
KRBP	- 0.0	VRAX

Risk-Adjusted Indicators

There is a big difference between Lixte Stock performing well and Lixte Biotechnology Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Lixte Biotechnology's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
ALLR	5.43	0.51	0.08	0.37	5.99	(6.49)	13.24	(11.76)	47.01
NRBO	3.99	(0.48)	0.00	(0.92)	0.00	0.00	8.05	(7.34)	25.83
HILS	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
VRAX	6.11	(0.04)	0.00	(0.21)	0.00	0.00	16.67	(11.98)	59.66
QNRX	5.39	(0.84)	0.00	(2.47)	0.00	0.00	14.29	(10.53)	57.78
INDP	3.54	(0.47)	0.00	0.95	0.00	0.00	6.33	(7.41)	20.25
KTTA	5.14	(0.66)	0.00	(0.28)	0.00	0.00	10.40	(10.75)	53.63
KRBP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
BDRX	5.10	(1.18)	0.00	(0.49)	0.00	0.00	11.58	(11.78)	52.99
PMVP	1.88	(0.35)	0.00	(0.35)	0.00	0.00	4.41	(3.65)	16.42

Lixte Biotechnology Corporate Management

Johannes MD	Chief Officer	Profile
James MD	Chief Officer	Profile
Robert Weingarten	VP CFO	Profile
Eric JD	VP COO	Profile
John MD	President, Founder	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC